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Abstract
Background: Non-concordance with medication remains a major public health problem that
imposes a considerable financial burden on the health care system, and there is still a need for
studies on correlates of non-concordance. Our first aim is to analyse whether any of the individual
characteristics age, educational level, financial strain, self-rated health, social participation, and trust
in the health care system are associated with primary non-concordance with medication. Our
second aim is to investigate whether people living in the same area have similar probability of
primary non-concordance with medication, that relates to area social participation.
Methods: We analysed cross sectional data from 9 070 women and 6 795 men aged 18 to 79
years, living in 78 areas in central Sweden, who participated in the Life & Health year 2000 survey,
with multilevel logistic regression (individuals at the first level and areas at the second level).
Results: Younger age, financial strain, low self-rated health, and low trust in the health care system
were associated with primary non-concordance with medication. However, area social
participation was not related to primary non-concordance, and the variation in primary non-
concordance between the areas was small.
Conclusion:  Our results indicate that people in central Sweden with younger age, financial
difficulties, low self-rated health, and low trust in the health care system may have a higher
probability of primary non-concordance with medication. However, the area of residence – as
defined by administrative boundaries – seems to play a minor role for primary non-concordance.
Background
Patients' concordance with medication is a prerequisite
for effective drug therapy. Non-concordance is a major
public health problem that imposes a considerable finan-
cial burden on the health care system [1,2]. Despite the
comprehensive research on concordance during the last
decades [3], non-concordance remains a concern in
health care, and there is still a need for studies on corre-
lates of non-concordance because the complex phenome-
non of non-concordance is far from understood. It has
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been suggested that the social context in which non-con-
cordance occurs should not be ignored [1,2,4], and we
have tried to incorporate this aspect in this study.
The term concordance implies agreement, trust, and har-
mony between patient and doctor regarding treatment,
and acknowledges the patient as a decision maker, and a
cornerstone is professional empathy [2,5]. The members
of a working party of the Royal Pharmaceutical Society of
Great Britain introduced the term concordance, which rec-
ognizes a patient's own choice to concord with treatment
[2].
Patient non-concordance with medication may be
divided into primary non-concordance, where the patient
does not redeem the prescription, and secondary non-
concordance, where the patient does not take the medica-
tion as prescribed [2,6]. Most studies have focused on sec-
ondary non-concordance [7-9]. Nevertheless, it is crucial
to determine whether patients actually redeem their pre-
scriptions from the pharmacy, because this is the first step
in the complex phenomenon of concordance [9]. Studies
on primary non-concordance have reported non-redemp-
tion rates between 2% and 33% [6-16]. However, these
studies vary greatly regarding assessment of primary non-
concordance, participants, and setting.
Individual characteristics, such as age, educational level,
self-rated health, and social support have been discussed
as correlates of concordance, however, the results are
inconsistent [1-3,17,18]. On the other hand, the influence
of area factors, related to one's area of residence, have
been scarcely investigated in relation to concordance. Yet,
over and above individual characteristics, patients' con-
cordance with medication might be related to the social
context in which they live [1,4]. In a previous study, we
observed that the association between social participation
and concordance with antihypertensives varied among
municipalities in Scania, Sweden (i.e., cross-level interac-
tion) [19], which suggests that the area of residence may
influence the mechanisms behind the concordance
behaviour.
Individual social participation describes how actively a
person takes part in activities, groups, and associations,
and social participation has been associated with health-
related behaviours, such as smoking cessation [20] and
physical activity [21]. Further, social participation is
important for understanding the influence of social fac-
tors on health [22], and can be viewed as a feature of indi-
vidual social networks [23]. Social participation and
social networks have been suggested to influence health
behaviours, such as concordance with medication, possi-
bly through information exchange and establishment of
health-related group norms [23,24]. In our previous study
in Scania, our results suggested an association between
low social participation and low concordance with anti-
hypertensives [19], and, therefore, we wanted to further
investigate whether social participation, both at the indi-
vidual and at the area level, was associated with general
primary non-concordance with medication, in a different
setting.
The area level of social participation has been considered
as a structural component within the concept of social
capital [24,25], which describes social structures and
social relationships in society [24]. Living in an area with
low social capital might decrease the individual probabil-
ity of concordance with medication through mechanisms
like poorer social networks [17], shared norms around
health-related behaviour, transmission of health informa-
tion, health care system factors [26], and social control
over deviant health-related behaviour [23,27]. Previous
studies have found associations between living in a disad-
vantaged area [28], with low social capital [29,30], and
use of medication. We were therefore interested in inves-
tigating whether social capital, as measured by the area
level of social participation, might be related to primary
non-concordance with medication.
Because of our contextual approach in this study, we used
multilevel analysis, which handles information on both
people and context simultaneously within the same
model [31], and we investigated measures of variation as
well as traditional measures of association [32,33].
The first aim of this study is to analyse whether any of the
individual characteristics age, educational level, financial
strain, self-rated health, social participation, and trust in
the health care system are associated with primary non-
concordance with medication. The second aim is to inves-
tigate whether people living in the same area have similar
probability of primary non-concordance with medica-
tion, that relates to area social participation.
Methods
Study sample
We used data from the Life & Health year 2000 survey
[34], a postal questionnaire administered by Statistics
Sweden. A random sample of 70 044 people, aged 18–79
years from 58 municipalities in six regions in central Swe-
den (Södermanland, Uppsala, Värmland, Västmanland,
and Örebro county, and south Dalarna), had the opportu-
nity to participate in the survey and 46 636 (67%)
returned the questionnaire. The purpose of the survey was
to generate self-reported information about people's life
and health in the area and was complemented with regis-
ter data on age, sex, place of residence, and educational
level. Of the 46 636 participants, we included those who
reported having visited an emergency department, a phy-BMC Public Health 2006, 6:52 http://www.biomedcentral.com/1471-2458/6/52
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sician at a hospital department, a primary care physician,
or been admitted to a hospital during the last 3 months (n
= 20 362), and with complete information on all the var-
iables studied (n = 9 070 women and 6 795 men).
The areas in this study correspond to municipalities,
except for Uppsala, Västerås, and Örebro (the three largest
cities in the sample region), which were divided into ten,
eight, and five smaller urban areas, respectively. In total,
there were 78 areas.
Outcome variable
Primary non-concordance with medication (dichotomous)
was assessed by the question "During the last 3 months,
have you received a prescription for medicine, but not
redeemed the medicine?"
Explanatory variables
The correlates of non-concordance were selected by
reviewing the literature and grouped into a) social and
economic factors and b) Health care system and area fac-
tors, as suggested by the World Health Organization
(WHO) [26].
Social and economic factors
Age was categorized into four groups: 18–34 years, 35–49
years, 50–64 years, and 65–79 years (used as reference cat-
egory).
Educational level was dichotomised into ≥9 years of educa-
tion (i.e., compulsory school) (low educational level) and
>9 years [35].
Financial strain was assessed by a negative answer to the
question, "Would you manage to raise 18 000 SEK (about
1900 Euro) in 1 week?" (dichotomous).
Self-rated health was assessed by the question "How do
you rate your general health status?" and dichotomised
into "neither good nor bad/bad/very bad health" (low
self-rated health) and "good/very good health" [36].
Individual social participation was defined by active mem-
bership [37] in a labour union, political party, council/
board, community centre, sports association, cultural
association/choir/orchestra/theatre group etc., religious
association/community, or other association. Participants
without any active membership in any of these associa-
tions were considered to have low social participation
(dichotomous).
Health care system and area factors
Trust in the health care system was assessed by the question
"How much do you trust the following institutions in
society?" and for "The health care system" indicating "not
particularly high trust/no trust/have no opinion" (low
trust in the health care system) and "very high trust/fairly
high trust" (dichotomous).
Area low social participation was based on a larger sample
from the Life & Health year 2000 survey (20 715 women
and 18 190 men), and was estimated by the proportion of
participants in the area who were classified as having low
social participation [29,30,37]. Area low social participa-
tion was then divided into tertiles.
Statistical analysis
We used multilevel logistic regression analysis [38] with
individuals at the first level and areas at the second level.
Men and women were analysed separately, in order to see
whether the associations between the explanatory varia-
bles and the outcome were different for men and women.
In Model i (empty model), we did not include any explan-
atory variables. In Model ii, we included only the individ-
ual variables, i.e., age, education, financial strain, self-
rated health, social participation, and trust in the health
care system. In Model iii, we added area low social partic-
ipation, because we wanted to investigate the influence of
area low social participation on primary non-concordance
with medication, after adjustment for the individual
(compositional) variables.
Fixed effects (measures of association)
The results are shown as odds ratios (ORs) with 95 % con-
fidence intervals (CIs).
Random effects (measures of variation)
We examined whether the area of residence had a general
contextual effect on individual primary non-concordance.
In other words, we wanted to establish whether individu-
als living in the same area shared a similar probability of
primary non-concordance, after adjusting for the individ-
ual characteristics studied. This hypothesized contextual
phenomenon [33] was measured by the intraclass correla-
tion (ICC) and the median odds ratio (MOR). We also
applied the 80% interval odds ratio (80%IOR), which
integrates random effects (i.e., area variance) in the meas-
urement of fixed effects (i.e., the area variable) [38,39].
We refer elsewhere[38,39] for a more detailed explanation
of the ICC, MOR and IOR. However, in short, the ICC is
the proportion of the total variance (i.e., the variance at
the area level plus the variance at the individual level) that
is at the area level. In the multilevel logistic regression,
there are different ways to calculate the ICC [40]; however,
we chose the threshold model, as described by Snijders &
Bosker [41]. An advantageous alternative to the ICC in the
multilevel logistic regression is the MOR, which measures
area variance in the odds ratio scale. If the MOR is equal
to 1 (no area level variance), there is no differenceBMC Public Health 2006, 6:52 http://www.biomedcentral.com/1471-2458/6/52
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between the areas regarding primary non-concordance.
Conversely, the higher the MOR, the more important the
contextual effects for understanding the individual proba-
bility of primary non-concordance.
The IOR considers the magnitude of the difference
between the areas regarding primary non-concordance
when interpreting the influence of area variables. It has
been suggested to report the IOR as an 80% interval, and
also, the IOR is not an ordinary confidence interval. If the
IOR contains 1, the remaining unexplained difference
between the areas regarding primary non-concordance is
large compared with the effect of the area variable. How-
ever, if the IOR does not contain 1, the effect of the area
variable is large compared with the unexplained differ-
ence between the areas.
The MLwiN software, version 2.0 [42], was used for the
analyses. Parameters were estimated using the Markov
Chain Monte Carlo (MCMC) procedure. We used the
default settings in MLwiN, i.e., chains of length 5 000 after
a burn-in of 500. The Deviance Information Criterion
(DIC) was used as a measure of how well our different
models fitted the data. A lower value on DIC indicates a
better fit of the model [43,44].
Results
The prevalence of primary non-concordance with medica-
tion was 7.6% (range across the 78 areas: 2%–14%) for
women and 6.5% (range across the 78 areas: 0%–15%)
for men in the study sample. Financial strain and low
social participation were more frequent among women
than among men (table 1).
Further, table 1 shows the distribution of active member-
ship in associations (social participation) in the study
sample. Active membership in sports associations was
fairly frequent (i.e., in 8.9% of women and 15.5% of
men). However, a large proportion of the participants
were members of "other", unknown, associations (i.e.,
22.7% of women and 26.5% of men).
The median (first to third quartile) number of participants
in the areas was 115 (102–126) women and 86 (72–94)
men. Area low social participation ranged from 45% to
63%.
Fixed effects
Social and economic factors
In Model ii, the association between age and primary non-
concordance with medication was inversed (table 2 and
3). Moreover, we did not find any association between
educational level and primary non-concordance, but we
found an association between financial strain and pri-
mary non-concordance (ORwomen = 1.87 (95% CI 1.58–
2.22) and ORmen = 2.24 (95% CI 1.82–2.75)). Also low
self-rated health (ORwomen = 1.38 (95% CI 1.16–1.63) and
ORmen = 1.58 (95% CI 1.28–1.95)) was associated with
primary non-concordance. The lower DIC value in Model
ii indicated a better fit than in Model i (the empty model).
Health care system and area factors
In Model ii, low trust in the health care system ((ORwomen
= 1.33 (95% CI 1.12–1.58) and ORmen = 1.37 (95% CI
1.11–1.69)) was related to primary non-concordance.
In Model iii, area low social participation was not associ-
ated with primary non-concordance. Furthermore, the
Table 1: Characteristics of the 9 070 women and 6 795 men from the Life & Health year 2000 survey, Sweden. Unless otherwise 
indicated, values are given in percent.
Women Men
Mean age 49 years 53 years
Primary non-concordance with medication 7.6 6.5
Low educational level 30.6 33.9
Financial strain 33.7 24.2
Low self-rated health 45.9 44.2
Low social participation 54.9 47.5
Low trust in the health care system 26.2 25.1
Active membership in associations (social participation)
Labour union 4.1 4.7
Political party 2.2 3.2
Council/board 2.9 2.7
Community centre 3.0 4.0
Sports association 8.9 15.5
Cultural association/choir/orchestra/theatre group, etc. 7.9 7.7
Religious association/community 6.1 4.5
Other association 22.7 26.5BMC Public Health 2006, 6:52 http://www.biomedcentral.com/1471-2458/6/52
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DIC value in Model iii showed that the addition of area
low social participation did not improve the fit.
Random effects
The area intercept variance in the different analyses was
small, ranging from 0.012 to 0.036 (table 2 and 3).
Accordingly, the MOR and the ICC were also small, the
MOR ranging from 1.11 to 1.20 and the ICC ranging from
0.4% to 1.1%.
Moreover, the 80%IORs included 1 for area low social
participation, and thereby confirmed the low importance,
in this study, of this area characteristic for primary non-
concordance.
We did not find any interaction between individual and
area social participation.
Discussion
Main findings
Our results indicate that the individual characteristics
younger age, financial strain, low self-rated health, and
low trust in the health care system are associated with pri-
mary non-concordance with medication. Our finding that
younger age is associated with higher primary non-con-
cordance is in line with previous studies on primary non-
concordance [10,13,15].
Research on education and concordance has been incon-
clusive [1,18], and we did not either find an association
between educational level and primary non-concordance.
However, there was a relation between financial strain
and primary non-concordance. All residents in Sweden
who have spent 1800 SEK (about 190 Euro) on medica-
tion within the preceding 12 months are entitled to free
prescribed medicines through the social security system
[45]. Despite this subsidy, participants in this study who
experienced financial strain seemed to have difficulties
redeeming their medication. It has previously been
reported that financial barriers contribute to non-con-
cordance [3,7,12,13,45-47], and that people who restrict
their use of medication because of cost have worse health
outcomes [48].
Also, we observed an association between low self-rated
health and primary non-concordance. However, previous
studies on self-rated health and concordance have given
different results [18].
Furthermore, we found a relation between low trust in the
health care system and primary non-concordance. There is
an ongoing discussion about the lack of people's trust in
health care system and health care professionals [49-55].
It is known that trust and the quality of the doctor-patient
relationship are important for concordance with medica-
Table 2: Area variance and odds ratios (ORs) with 95% confidence intervals (95% CIs) for individual variables and area low social 
participation regarding primary non-concordance with medication among 9 070 women from the Life & Health year 2000 survey, 
Sweden.
Model i (empty model) Model ii Model iii
OR 95% CI OR 95% CI OR 95% CI 80% IOR
Fixed effects
Age
65–79 years Ref Ref
50–64 years 1.58 (1.16–2.15) 1.55 (1.18–2.03)
35–49 years 2.49 (1.82–3.43) 2.46 (1.88–3.22)
18–34 years 3.22 (2.36–4.39) 3.17 (2.41–4.17)
Low educational level (yes vs. no) 0.85 (0.71–1.03) 0.85 (0.71–1.03)
Financial strain (yes vs. no) 1.87 (1.58–2.22) 1.85 (1.57–2.18)
Low self-rated health (yes vs. no) 1.38 (1.16–1.63) 1.37 (1.16–1.62)
Low social participation (yes vs. no) 0.87 (0.74–1.02) 0.86 (0.73–1.02)
Low trust in the health care system (yes vs. no) 1.33 (1.12–1.58) 1.34 (1.13–1.58)
Area low social participation in tertiles
1 Ref
2 1.22 (0.99–1.50) 0.98–1.51
3 1.10 (0.89–1.35) 0.88–1.36
Random effects
Area intercept variance (SE) 0.014(0.015) 0.012(0.013) 0.014(0.015)
Median odds ratio 1.12 1.11 1.12
Intraclass correlation 0.4% 0.4% 0.4%
Deviance information criterion 4888 4686 4686BMC Public Health 2006, 6:52 http://www.biomedcentral.com/1471-2458/6/52
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tion [2,51,56-58]. Possible ways to enhance patient trust
may be continuity of care from a regular doctor [59] and
provision of patient centred care where the patient gets
enough attention [60]. Future studies of why some people
have low trust in the health care system and how this trust
can be enhanced are needed.
Further, area social participation was not associated with
primary non-concordance with medication. The low
importance of the area is further supported by the low
area variances and, hence, the low MORs in the analyses,
which indicate that the area of residence, as measured in
this study, does not seem to be important for primary
non-concordance. Nevertheless, one alternative explana-
tion could be that the choice of areas in this study as
municipalities and the way we measured the aggregated
variable area social participation did not capture the con-
text important for primary non-concordance. We expected
area social participation, a main aspect of social capital, to
be related to primary non-concordance with medication
because of mechanisms like poorer social networks,
shared norms around health-related behaviour, transmis-
sion of health information, and social control over devi-
ant health-related behaviour [23,27]. Indeed, related
research suggests that social capital and deprivation plays
a role in use of medication [28,30], how health care is per-
ceived by citizens [61] and people's trust in their physi-
cians may be influenced by contextual variables [62].
Limitations
The study sample consisted of those who had visited an
emergency department, a physician at a hospital depart-
ment, a primary care physician, or been admitted to a hos-
pital. With this definition of population at risk we tried to
include individuals that had had some contact with the
health care system and therefore could have received a
prescription. However, this definition may not adequately
capture people "at risk" of not redeeming a prescription
for medicine.
We used self-reported concordance, which has been
found to correlate with other measures of concordance
and with clinical measures of disease activity [63-65]. Fur-
ther, self-report offers a convenient and non-invasive esti-
mate of concordance behaviour. However, the procedure
of measuring concordance is controversial. Self-report can
be subject to self-presentational and recall biases. People
may overestimate their concordance and their memory
may be inaccurate [66].
The WHO has suggested five sets of correlates of non-con-
cordance: social and economic factors, health care system
Table 3: Area variance and odds ratios (ORs) with 95% confidence intervals (95% CIs) for individual variables and area low social 
participation regarding primary non-concordance with medication among 6 795 men from the Life & Health year 2000 survey, 
Sweden.
Model i (empty model) Model ii Model iii
OR 95% CI OR 95% CI OR 95% CI 80% IOR
Fixed effects
Age
65–79 years Ref Ref
50–64 years 1.57 (1.18–2.09) 1.57 (1.17–2.09)
35–49 years 2.23 (1.64–3.04) 2.19 (1.61–2.98)
18–34 years 2.29 (1.67–3.13) 2.26 (1.62–3.16)
Low educational level (yes vs. no) 0.87 (0.69–1.10) 0.87 (0.70–1.09)
Financial strain (yes vs. no) 2.24 (1.82–2.75) 2.25 (1.84–2.76)
Low self-rated health (yes vs. no) 1.58 (1.28–1.95) 1.58 (1.29–1.93)
Low social participation (yes vs. no) 0.85 (0.69–1.03) 0.85 (0.69–1.03)
Low trust in the health care system (yes vs. no) 1.37 (1.11–1.69) 1.38 (1.11–1.72)
Area low social participation in tertiles
1 Ref
2 1.07 (0.80–1.43) 0.76–1.51
3 0.83 (0.62–1.11) 0.59–1.17
Random effects
Area intercept variance (SE) 0.034(0.033) 0.034(0.033) 0.036(0.025)
Median odds ratio 1.19 1.19 1.20
Intraclass correlation 1.0% 1.0% 1.1%
Deviance information criterion 3288 3148 3148BMC Public Health 2006, 6:52 http://www.biomedcentral.com/1471-2458/6/52
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factors, condition-related factors, therapy-related factors,
and patient-related factors [26]. We have only addressed
two of these five sets of correlates: social and economic
factors and health care system and area factors. Future
studies of non-concordance may try to also capture the
less often studied condition-related factors, such as sever-
ity of symptoms, and therapy-related factors, such as the
complexity of the medical regimen.
People living in deprived areas and with low socio-eco-
nomic status, low self-rated health, and primary non-con-
cordance with medication may have been less inclined to
respond to the Life & Health year 2000 survey. Analyses of
the excluded responders with incomplete information on
the variables studied showed that they were, in general,
older, and had lower educational level and lower self-
rated health, than those included in this study. This possi-
ble selection bias could lead to an underestimation of the
associations between the explanatory variables in this
study and the outcome primary non-concordance with
medication.
The cross-sectional design of this study is a weakness,
because the direction of causality is impossible to deter-
mine. However, the direction of causality from individual
characteristics to primary non-concordance seems to be
the most plausible.
Conclusion
Our results indicate that people in central Sweden with
younger age, financial difficulties, low self-rated health,
and low trust in the health care system may have a higher
probability of primary non-concordance with medica-
tion. However, the area of residence – as defined by
administrative boundaries – seems to play a minor role
for primary non-concordance.
Future studies of why some people have low trust in the
health care system and how this trust can be enhanced are
needed.
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